allylamine has been researched along with Hypercholesterolemia in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (6.00) | 18.2507 |
2000's | 30 (60.00) | 29.6817 |
2010's | 16 (32.00) | 24.3611 |
2020's | 1 (2.00) | 2.80 |
Authors | Studies |
---|---|
Esan, O; Viljoen, A; Wierzbicki, AS | 1 |
Jialal, I; Sheely, D | 1 |
Bloks, VW; Boverhof, R; de Boer, RA; Groen, AK; Havinga, R; Kuipers, F; Meissner, M; Wolters, H | 1 |
Ishisaka, DY; Jukes, T; Leahy, A; Qian, C; Romanelli, RJ; Ye, X | 1 |
Ishisaka, DY; Jukes, T; Kang, A; Leahy, A; Romanelli, RJ; Ye, X | 1 |
Dayer-Berenson, L; Finckenor, M | 1 |
Brønden, A; Hansen, M; Knop, FK; Rohde, U; Sonne, DP; Vilsbøll, T | 1 |
Bays, H; Li, Y; Louder, A; Mallick, R; Schwab, P | 1 |
Fonseca, VA; Goldberg, RB; Jones, MR; Truitt, KE | 1 |
Corsini, A; Farnier, M; Windler, E | 1 |
Handelsman, Y | 2 |
Fonseca, VA; Goldfine, AB | 1 |
Staels, B | 1 |
Hagan, MA; Simons, WR | 1 |
Lee, T | 1 |
Davidson, MH; Donovan, JM; Jones, MR; Misir, S | 1 |
Avitabile, N; Banka, A; Fonseca, VA | 1 |
Brunetti, L; Campbell, RK | 1 |
Aggarwal, S; Arora, RR; Loomba, RS | 1 |
Elisaf, MS; Florentin, M; Kei, AA; Kostapanos, MS; Liamis, G; Liberopoulos, EN; Rizos, CV | 1 |
Athyros, VG; Karagiannis, A; Mikhailidis, DP; Tziomalos, K | 1 |
Bretz, F; Hothorn, LA; Hsu, JC | 1 |
Bays, H; Dujovne, C | 1 |
Melian, EB; Plosker, GL | 1 |
Farmer, JA; Manhas, A | 1 |
Ballantyne, CM; Chiou, P; Guyton, JR; Jones, PH; Stein, JL; Xydakis, AM | 1 |
Larsen, ML; Raungaard, B | 1 |
Rosenson, RS | 1 |
Burke, SK; Donovan, JM; Illingworth, DR; Isaacsohn, J; Olson, T; Pappu, AS; Setchell, KD; Von Bergmann, K | 1 |
Abby, SL; Bays, HE; Davidson, M; Jones, MR | 1 |
Autret, B; Devaraj, S; Jialal, I | 1 |
Abby, S; Bays, H; Jones, M; Lai, YL; Rhyne, J | 1 |
Anderson, S; Fish, B; Knopp, RH; Nguyen, H; Nguyen, T; Retzlaff, BM; Tsunehara, C | 1 |
Keating, GM; Robinson, DM | 1 |
Goldberg, DJ; Nicolosi, RJ; Rogers, EJ; Sacchiero, R; Wilson, TA | 1 |
Burke, SK; Davidson, MH; Dillon, MA; Gordon, B; Isaacsohn, J; Jones, P; Samuels, J; Toth, P; Weiss, S | 1 |
Henney, JE | 1 |
Burke, SK; Chin, B; Davidson, MH; Donovan, JM; Gaziano, JM; Knapp, HH; Knopp, R; Ma, P; Schrott, H | 1 |
Burke, SK; Davidson, MH; Donovan, JM; Hunninghake, D; Isaacsohn, J; McKenney, J; Toth, P; Weiss, S | 1 |
Burke, SK; Davidson, D; Donovan, JM; Hunninghake, D; Insull, W; Toth, P | 1 |
Burke, S; Davidson, MH; Donovan, JM; Hunninghake, D; Insull, W; Mullican, W; Toth, P | 1 |
Steinmetz, KL | 1 |
16 review(s) available for allylamine and Hypercholesterolemia
Article | Year |
---|---|
Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.
Topics: Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; Lipids; Suspensions; Tablets | 2014 |
Sevelamer in a diabetologist's perspective: a phosphate-binding resin with glucose-lowering potential.
Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; Hypoglycemic Agents; Polyamines; Sevelamer; Treatment Outcome; Triglycerides | 2015 |
Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Interactions; Humans; Hypercholesterolemia | 2009 |
The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.
Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; United States | 2009 |
The role of colesevelam HCl in type 2 diabetes mellitus therapy.
Topics: Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; Life Style; Patient Education as Topic; Primary Prevention; United States | 2009 |
A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.
Topics: Allylamine; Animals; Anticholesteremic Agents; Bile Acids and Salts; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; United States | 2009 |
Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes.
Topics: Adult; Allylamine; Animals; Anticholesteremic Agents; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Randomized Controlled Trials as Topic | 2011 |
Clinical efficacy of colesevelam in type 2 diabetes mellitus.
Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Humans; Hypercholesterolemia; Randomized Controlled Trials as Topic | 2011 |
Efficacy of colesevelam on lowering glycemia and lipids.
Topics: Allylamine; Animals; Anticholesteremic Agents; Blood Glucose; Cholesterol; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; Triglycerides | 2012 |
Colesevelam: a new and improved bile acid sequestrant?
Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; C-Reactive Protein; Cholesterol, LDL; Clinical Trials as Topic; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia | 2013 |
Colesevelam HCl: a non-systemic lipid-altering drug.
Topics: Allylamine; Animals; Child; Clinical Trials as Topic; Colesevelam Hydrochloride; Drug Interactions; Female; Half-Life; Humans; Hypercholesterolemia; Hypolipidemic Agents | 2003 |
Colesevelam.
Topics: Allylamine; Clinical Trials as Topic; Colesevelam Hydrochloride; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents | 2001 |
Hypolipidemic therapy and cholesterol absorption.
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol; Colesevelam Hydrochloride; Ezetimibe; Humans; Hypercholesterolemia; Intestinal Absorption | 2004 |
Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Topics: Allylamine; C-Reactive Protein; Cholagogues and Choleretics; Cholesterol; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 2006 |
Colesevelam: a review of its use in hypercholesterolemia.
Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Therapy, Combination; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents | 2007 |
Colesevelam hydrochloride.
Topics: Allylamine; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents | 2002 |
14 trial(s) available for allylamine and Hypercholesterolemia
Article | Year |
---|---|
Colesevelam in the treatment of hypercholesterolemia and hyperglycemia: a retrospective analysis from an ambulatory care medical network.
Topics: Adolescent; Adult; Aged; Allylamine; Ambulatory Care; Anticholesteremic Agents; California; Cholesterol, LDL; Colesevelam Hydrochloride; Female; Humans; Hypercholesterolemia; Hyperglycemia; Male; Middle Aged; Retrospective Studies | 2013 |
Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Topics: Adolescent; Adult; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypoglycemic Agents; Insulin; Male; Mexico; Middle Aged; Prospective Studies; Treatment Outcome; United States | 2008 |
A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
Topics: Adult; Aged; Alanine Transaminase; Allylamine; Anticholesteremic Agents; Aspartate Aminotransferases; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged | 2010 |
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.
Topics: Aged; Allylamine; Anticholesteremic Agents; Biomarkers; Blood Glucose; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Prediabetic State; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2013 |
Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia.
Topics: Allylamine; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Particle Size; Triglycerides | 2006 |
Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia.
Topics: Allylamine; Bile Acids and Salts; Cholesterol; Cholesterol, LDL; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Feces; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Sterols; Treatment Outcome | 2005 |
Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemia.
Topics: Adult; Allylamine; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Follow-Up Studies; Humans; Hypercholesterolemia; Inflammation; Treatment Outcome | 2006 |
Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
Topics: Adult; Aged; Aged, 80 and over; Allylamine; Apolipoprotein A-I; Apolipoproteins B; Azetidines; Cholesterol; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Patient Compliance; Treatment Outcome | 2006 |
Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Pilot Projects; Triglycerides | 2006 |
Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.
Topics: Adult; Aged; Allylamine; Bile Acids and Salts; Cholagogues and Choleretics; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Digestive System; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Lipids; Male; Middle Aged; Triglycerides | 1999 |
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
Topics: Adult; Aged; Allylamine; Analysis of Variance; Anticholesteremic Agents; Apolipoproteins; Cholagogues and Choleretics; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Middle Aged; Simvastatin; Treatment Outcome; Triglycerides | 2001 |
Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia.
Topics: Allylamine; Analysis of Variance; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Treatment Outcome | 2001 |
Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively.
Topics: Adult; Aged; Allylamine; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyrroles; Triglycerides | 2001 |
Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.
Topics: Adult; Aged; Allylamine; Analysis of Variance; Anticholesteremic Agents; Apolipoproteins B; Cholesterol, LDL; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Statistics, Nonparametric; Treatment Outcome | 2001 |
20 other study(ies) available for allylamine and Hypercholesterolemia
Article | Year |
---|---|
Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia.
Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperglycemia; Hyperlipidemias; Hypolipidemic Agents; Triglycerides | 2022 |
Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk.
Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2013 |
Bile acid sequestration normalizes plasma cholesterol and reduces atherosclerosis in hypercholesterolemic mice. No additional effect of physical activity.
Topics: Allylamine; Animal Feed; Animals; Anticholesteremic Agents; Aorta; Atherosclerosis; Bile Acids and Salts; Cardiac Output; Cholesterol; Colesevelam Hydrochloride; Echocardiography; Feces; Hypercholesterolemia; Liver; Male; Mice; Mice, Knockout; Physical Conditioning, Animal; Receptors, LDL; Sterols | 2013 |
Multivariate analysis of factors associated with persistent colesevelam treatment among patients with hypercholesterolemia.
Topics: Adolescent; Adult; Aged; Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Multivariate Analysis; Treatment Outcome; Young Adult | 2013 |
Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allylamine; Anticholesteremic Agents; Azetidines; Cohort Studies; Colesevelam Hydrochloride; Coronary Artery Disease; Diagnosis-Related Groups; Ezetimibe; Female; Health Services for the Aged; Humans; Hypercholesterolemia; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United States | 2014 |
What role for [black triangle down] colesevelam in cardiovascular prevention?
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Colesevelam Hydrochloride; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Treatment Outcome | 2009 |
The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction.
Topics: Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Blood Glucose; Centers for Disease Control and Prevention, U.S.; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypercholesterolemia; United States | 2009 |
An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
Topics: Adult; Aged; Allylamine; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Cost-Benefit Analysis; Databases, Factual; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Health Care Costs; Humans; Hypercholesterolemia; Insulin; Male; Metformin; Middle Aged; Models, Economic; Randomized Controlled Trials as Topic; Risk; Sulfonylurea Compounds; Treatment Outcome; United States | 2010 |
Ask the doctor. I have tried all of the statin drugs to lower my cholesterol, but each one has caused severe muscle pain. Are there any non-statin medications I could try using to lower my cholesterol?
Topics: Allylamine; Azetidines; Colesevelam Hydrochloride; Diet, Mediterranean; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases; Niacin; Pain; Sitosterols | 2010 |
[Hypercholesterolemia: when statins are not enough or not tolerated. With combination therapy to LDL cholesterol target goal].
Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Randomized Controlled Trials as Topic | 2012 |
Identifying effective and/or safe doses by stepwise confidence intervals for ratios.
Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Clinical Trials, Phase III as Topic; Colesevelam Hydrochloride; Confidence Intervals; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypercholesterolemia; Numerical Analysis, Computer-Assisted; Research Design; Simvastatin | 2003 |
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2004 |
[Colesevelam hydrochloride. A product description].
Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Drug Therapy, Combination; Humans; Hypercholesterolemia | 2005 |
Lower cholesterol without statins. Options are available.
Topics: Allylamine; Azetidines; Cholesterol, LDL; Cholinergic Antagonists; Colesevelam Hydrochloride; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Phytosterols | 2006 |
Studies of cholesterol and bile acid metabolism, and early atherogenesis in hamsters fed GT16-239, a novel bile acid sequestrant (BAS).
Topics: Allylamine; Animals; Anticholesteremic Agents; Aortic Diseases; Arteriosclerosis; Aryl Hydrocarbon Hydroxylases; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Cricetinae; Cytochrome P-450 Enzyme System; Feces; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Lipoproteins; Liver; Male; Mesocricetus; Polyamines; Steroid Hydroxylases | 1998 |
Colesevelam. GT 31104, CholestaGel.
Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drugs, Investigational; Humans; Hypercholesterolemia | 1999 |
From the Food and Drug Administration.
Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrogels; Hypercholesterolemia; Lung Neoplasms; Surgical Equipment; United States; United States Food and Drug Administration | 2000 |
Colesevelam (Welchol) for hypercholesterolemia.
Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Digestive System; Drug Interactions; Humans; Hypercholesterolemia; Intestinal Absorption; Randomized Controlled Trials as Topic | 2000 |
New cholesterol-lowering drug is now available.
Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Humans; Hypercholesterolemia | 2001 |
Colesevelam hydrochloride.
Topics: Allylamine; Clinical Trials as Topic; Colesevelam Hydrochloride; Digestive System; Drug Interactions; Drug Labeling; Humans; Hypercholesterolemia; Hypolipidemic Agents | 2002 |